期刊
DIGESTIVE DISEASES AND SCIENCES
卷 57, 期 8, 页码 2233-2240出版社
SPRINGER
DOI: 10.1007/s10620-012-2140-5
关键词
Ipilimumab; Drug-induced hepatitis; CTLA-4; Immunosuppressive therapy; Metastatic melanoma
资金
- Bristol-Myers Squibb Co.
- US National Institutes of Health (National Cancer Institute)